My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 574

    1.

    Insulin action in the double incretin receptor knockout mouse.

    Ayala JE, Bracy DP, Hansotia T, Flock G, Seino Y, Wasserman DH, Drucker DJ.

    Diabetes. 2008 Feb;57(2):288-97. Epub 2007 Oct 31.PMID: 17977951 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.

    Ayala JE, Bracy DP, James FD, Julien BM, Wasserman DH, Drucker DJ.

    Endocrinology. 2009 Mar;150(3):1155-64. Epub 2008 Nov 13.PMID: 19008308 [PubMed - indexed for MEDLINE]Related articles

    3.

    Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.

    Hansotia T, Baggio LL, Delmeire D, Hinke SA, Yamada Y, Tsukiyama K, Seino Y, Holst JJ, Schuit F, Drucker DJ.

    Diabetes. 2004 May;53(5):1326-35.PMID: 15111503 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice.

    Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Granner DK, Wasserman DH.

    Diabetes. 2004 Feb;53(2):306-14.PMID: 14747279 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.

    Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y, Drucker DJ.

    J Clin Invest. 2007 Jan;117(1):143-52. Epub 2006 Dec 21.PMID: 17187081 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II.

    Fueger PT, Lee-Young RS, Shearer J, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH.

    Diabetes. 2007 Oct;56(10):2476-84. Epub 2007 Jul 16.PMID: 17639019 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.

    Flock G, Baggio LL, Longuet C, Drucker DJ.

    Diabetes. 2007 Dec;56(12):3006-13. Epub 2007 Aug 23.PMID: 17717280 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

    Hansotia T, Drucker DJ.

    Regul Pept. 2005 Jun 15;128(2):125-34. Review.PMID: 15780432 [PubMed - indexed for MEDLINE]Related articles

    9.

    Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity.

    Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC.

    PLoS One. 2009;4(3):e4937. Epub 2009 Mar 19.PMID: 19295913 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.

    Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, Cline G, Li H, Prentki M, Shulman GI, Mitchell GA, Kim JK.

    Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E30-9. Epub 2005 Feb 8.PMID: 15701680 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.

    Haluzik M, Gavrilova O, LeRoith D.

    Endocrinology. 2004 Apr;145(4):1662-7. Epub 2003 Dec 11.PMID: 14670996 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice.

    Sung HK, Kim YW, Choi SJ, Kim JY, Jeune KH, Won KC, Kim JK, Koh GY, Park SY.

    Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E402-9. Epub 2009 Jun 2.PMID: 19491299 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.

    Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW.

    Diabetes. 1997 Nov;46(11):1768-74.PMID: 9356024 [PubMed - indexed for MEDLINE]Related articles

    14.

    Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.

    van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL, Bergman RN.

    J Clin Endocrinol Metab. 2002 Nov;87(11):5191-8.PMID: 12414891 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse.

    Ayala JE, Bracy DP, McGuinness OP, Wasserman DH.

    Diabetes. 2006 Feb;55(2):390-7.PMID: 16443772 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice.

    Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH.

    Diabetes. 2007 Apr;56(4):1025-33. Epub 2007 Jan 17.PMID: 17229936 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.

    McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR.

    Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1746-55. Epub 2007 Sep 11.PMID: 17848629 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.

    Parlevliet ET, Schröder-van der Elst JP, Corssmit EP, Picha K, O'Neil K, Stojanovic-Susulic V, Ort T, Havekes LM, Romijn JA, Pijl H.

    J Pharmacol Exp Ther. 2009 Jan;328(1):240-8. Epub 2008 Oct 10.PMID: 18849357 [PubMed - indexed for MEDLINE]Related articles

    19.

    PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.

    van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM, Pijl H.

    Diabetes. 2004 Aug;53(8):1949-52.PMID: 15277371 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.

    Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M.

    Endocrinology. 2006 Sep;147(9):4517-24. Epub 2006 Jun 1.PMID: 16740970 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity